Thai FDA Approves NUZOLVENCE® for Gonorrhoea Treatment

Thai FDA Approves NUZOLVENCE® for Gonorrhoea Treatment

The Thai Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin), a first-in-class oral antibiotic designed to treat uncomplicated urogenital gonorrhoea in adults and paediatric patients aged 12 years and… Read more